Crosslay Remedies Profile
Key Indicators
- Authorised Capital ₹ 157.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 143.19 Cr
as on 16-11-2024
- Company Age 22 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 250.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 983.96 Cr
as on 16-11-2024
- Revenue 16.13%
(FY 2023)
- Profit 40.61%
(FY 2023)
- Ebitda 23.90%
(FY 2023)
- Net Worth 58.71%
(FY 2023)
- Total Assets 31.76%
(FY 2023)
About Crosslay Remedies
The Corporate was formerly known as Crosslay Remedies Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 157.00 Cr and a paid-up capital of Rs 143.19 Cr.
The company currently has active open charges totaling ₹250.00 Cr. The company has closed loans amounting to ₹983.96 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Crosslay Remedies Limited India are Gaurav as COMPANY SECRETARY and Umang Jaiswal as Cfo. Vandana Pakle, Anas Wajid, Mradul Kaushik, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239DL2002PLC113719
- Company No.
113719
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2002
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Crosslay Remedies?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gaurav | Company Secretary | 02-Feb-2023 | Current |
| Umang Jaiswal | CFO | 02-Feb-2023 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vandana Pakle  | Director | 04-Feb-2020 | Current |
| Anas Wajid | Director | 01-Jan-2019 | Current |
| Mradul Kaushik | Director | 18-Oct-2019 | Current |
| Yogesh Sareen | Director | 10-Jul-2015 | Current |
Financial Performance and Corporate Structure Insights of Crosslay Remedies.
Crosslay Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.13% increase. The company also saw a substantial improvement in profitability, with a 40.61% increase in profit. The company's net worth Soared by an impressive increase of 58.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Crosslay Remedies?
In 2023, Crosslay Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eqova Healthcare Private LimitedActive 3 years 9 monthsVandana Pakle and Yogesh Sareen are mutual person
Radiant Life Care FoundationActive 8 years 8 monthsVandana Pakle and Mradul Kaushik are mutual person
- Max Hospitals And Allied Services LimitedActive 10 years 7 months
Vandana Pakle and Mradul Kaushik are mutual person
Alexis Multi-Speciality Hospital Private LimitedActive 16 years 6 monthsVandana Pakle, Mradul Kaushik and 1 more are mutual person
Hometrail Buildtech Private LimitedActive 16 years 7 monthsAnas Wajid and Yogesh Sareen are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Dec 2020 | ₹200.00 Cr | Open |
Others Creation Date: 23 Dec 2020 | ₹50.00 Cr | Open |
Axis Bank Limited Creation Date: 20 Nov 2018 | ₹75.00 Cr | Satisfied |
How Many Employees Work at Crosslay Remedies?
Crosslay Remedies has a workforce of 1434 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Crosslay Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Crosslay Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
